Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

The Oranae County (CA) Register (10/22, Rokos, 546K) reports, "Attorneys will argue for significantly different prison terms Friday, Oct. 23, when Enrique Marquez Jr. is sentenced for supplying the weapons used in the Dec. 2, 2015, terrorist shooting in San Bernardino that killed 14 people and wounded 22 others."

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

rrorists-to-be-sentenced-fridayt> (10/22, Rokos, 546K) reports, "Attorneys will argue for significantly different prison terms Friday, Oct. 23, when Enrique Marquez Jr. is sentenced for supplying the weapons used in the Dec. 2, 2015, terrorist shooting in San Bernardino that killed 14 people and wounded 22 others."

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

The Orange County (CA) Register (10/22, Rokos, 546K) reports, "Attorneys will argue for significantly different prison terms Friday, Oct. 23, when Enrique Marquez Jr. is sentenced for supplying the weapons used in the Dec. 2, 2015, terrorist shooting in San Bernardino that killed 14 people and wounded 22 others."